KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $3.5 billion.

  • Cme Group's Consolidated Net Income fell 0.53% to $908.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 8.60%. This contributed to the annual value of $3.5 billion for FY2024, which is 9.29% up from last year.
  • Per Cme Group's latest filing, its Consolidated Net Income stood at $3.5 billion for FY2024, which was up 9.29% from $3.2 billion recorded in FY2023.
  • Cme Group's Consolidated Net Income's 5-year high stood at $3.5 billion during FY2024, with a 5-year trough of $2.1 billion in FY2020.
  • Moreover, its 3-year median value for Consolidated Net Income was $3.2 billion (2023), whereas its average is $3.1 billion.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first decreased by 0.44% in 2020, then rose by 25.19% in 2021.
  • Over the past 5 years, Cme Group's Consolidated Net Income (Yearly) stood at $2.1 billion in 2020, then increased by 25.19% to $2.6 billion in 2021, then rose by 2.05% to $2.7 billion in 2022, then rose by 19.89% to $3.2 billion in 2023, then rose by 9.29% to $3.5 billion in 2024.